Key Companies Covered in the Global Repositioning and Offloading Devices Market Research Report by Research Nester are Molnlycke Health Care AB, PfBeechfield Healthcare Ltd, V Guldmann A/S, Sage Products LLC, Hill-Rom Services, Inc., Frontier Medical Group, Walgreen Health Solutions, LLC., Stryker Corporation, Seneca Devices, Inc., and other key market players.
New York, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Research Nester has published a detailed market report on ‘Global Repositioning and Offloading Devices Market’ for the forecast period, i.e. 2022 – 2031 which includes the following factors:
Market growth over the forecast period
Key market players and their detailed profiling
Global Repositioning and Offloading Devices Market Size:
The global repositioning and offloading devices market is estimated to grow at a CAGR of ~6% over the forecast period. A growing number of individuals with diabetic foot ulcers is anticipated to be the responsible for the market's expansion. An open sore or wound that typically develops on the bottom of the foot is known as a diabetic foot ulcer. By relieving pressure, increasing healing, and reducing the risk of amputation, repositioning and offloading devices are particularly useful when treating diabetic foot ulcers. For instance, according to National Library of Medicine around 9.1 to 26.1 million diabetic foot ulcers occur each year worldwide and in their lifetime, 15 to 25% of people with diabetes mellitus anticipated to get a diabetic foot ulcer. Moreover, anyone who has diabetes have high chances to get foot ulcers, which is why the global market for repositioning and offloading devices is expected to rise significantly over the next several years.
Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4091
Global Repositioning and Offloading Devices Market: Key Takeaways
North America region gains a noteworthy share of the revenue
Patient turning & positioning systems segment hold a significant share of the revenue graph
Hospitals segment remains prominent in the end-user segment
Growing Geriatric Population and Increasing Hospitalization Cases to Boost Market Growth
Diabetes is more common in the aging population. A UN estimate predicts that by 2050, the population of elderly people would have grown by 16%. Apart from diabetes, various pressure ulcers are primarily brought on by immobility. Elderly adults and patients with spine or back problems are more likely to experience it and this in turn is anticipated to boost the market growth over the forecast period. According to statistics, 33% of persons 65 and older have diabetes, compared to younger people with diabetes, this population is more susceptible to developing chronic disability problems.
Moreover, the increasing cases of hospitalization on account of chronic diseases, namely, diabetes, cardiovascular diseases, end-stage kidney disease (ESKD), and spinal cord injuries, where its mandate to admit patients to the hospital and considering the severity of the ailments, repositioning and offloading devices are used for the daily movement of the patients. As per the data by the National Institute of Health, end-stage renal disease (ESRD), affects around 786,000 people in the US, with 71% receiving dialysis and 29% receiving a kidney transplant.
For more information in the analysis of this report, visit: https://www.researchnester.com/reports/repositioning-and-offloading-devices-market/4091
Global Repositioning and Offloading Devices Market: Regional Overview
The global repositioning and offloading devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.
Increasing Cases of Diabetes to Drive Growth in the Asia Pacific Region
The market in Asia Pacific region is estimated to thrive over the forecast period owing to the increasing number of diabetes patients in the region. According to World Health Organization, an enormous concern, diabetes affects 8.7% of people in India between the ages of 20 and 70, and it affects about 10% of adults in China or 110 million people, and by 2040, that number is projected to rise to 150 million. Along with this, the rising geriatric population in the region who are prone to chronic diseases and need more hospitalization are estimated to drive market growth during the forecast period.
Rising Healthcare Expenditure to Drive Growth in the North America Region
On the other hand, the market in North America region is estimated to gain a noteworthy market share over the forecast period owing to the increasing prevalence of chronic diseases and rising healthcare expenditure in the region. As per the Centers for Medicare and Medicaid Services, the national health expenditure of the USA has increased by 9.7% to USD4.1 trillion in 2020, or USD12,530 per person, and it represented 19.7% of GDP. Moreover, the presence of key market players and increasing investment by key players in medical technology are anticipated to propel the market growth over the forecast period.
Get a Sample PDF of Repositioning and Offloading Devices Market Report@ https://www.researchnester.com/sample-request-4091
The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in:
North America (U.S., Canada)
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific)
Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Global Repositioning and Offloading Devices Market, Segmentation by End User
Out of these, the hospital segment is estimated to hold a notable market share over the forecast period as there are very ill individuals in hospitals who are unable to move to reposition themselves. Healthcare experts assist individuals in changing their position in these situations to avoid the formation of pressure ulcers. The global repositioning and offloading devices market is anticipated to experience remarkable growth over the forecast period as a result of the rising hospital patient flow and increasing spending on healthcare across the globe. As per one of the expenditure data reports, global health spending has increased overall during the previous 20 years, doubling in real terms, reaching USD 8.5 trillion in 2019 and 9.8% of GDP (up from 8.5% in 2000).
For more insights on the market share of various regions: https://www.researchnester.com/sample-request-4091
Global Repositioning and Offloading Devices Market, Segmentation by Product Type
Patient Turning & Positioning Systems
Among these, the patient turning & positioning systems segment is estimated to gain a significant market share over the forecast period owing to increasing cases of spinal cord injuries which often lead to partial or full disability, and patients with this condition require the support of turning and positioning systems for basic movements. It is believed that every year, between 250 000 to 500 000 persons suffer a spinal cord injury in the world (SCI). Moreover, the increasing disposable income in the developed and developing nations and rising spending on healthcare is anticipated to boost the segment growth over the ensuing years.
Few of the well-known market leaders in the global repositioning and offloading devices market that are profiled by Research Nester are Molnlycke Health Care AB, PfBeechfield Healthcare Ltd, V Guldmann A/S, Sage Products LLC, Hill-Rom Services, Inc., Frontier Medical Group, Walgreen Health Solutions, LLC., Stryker Corporation, Seneca Devices, Inc., and others.
Do You Have Any Query Or Specific Requirement? Ask to Our Expert: https://www.researchnester.com/ask-the-analyst/rep-id-4091
Recent Developments in the Global Repositioning and Offloading Devices Market
In February 2022, the total bed management by Beechfield Healthcare has been made available at Tallaght University Hospital, it is one of its kind bed management solution for public hospital.
In March 2022, One of the top manufacturers of medical technology, Stryker, unveiled the first linked ambulance cot. The Power-PRO 2 powered ambulance cot builds on the innovation of its predecessor and delivers enhanced movement, increased safety, and connectivity tools to assist maximize time and money.
Explore Our Recent Related Reports:
Ulcerative Colitis Market Segmentation By Procedure (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis Colitis and Fulminant Colitis); By Medication (5-Aminosalicylates, Steroids, Purine Analogs, Immuno-modulators and Biologics) - Global Demand Analysis & Opportunity Outlook 2027 Continuous Glucose Monitoring Market Segmentation By Component (Integrated Insulin Pumps, Transmitters & Receivers and Sensors); By Demographics (Child Population (<=14 Years) & Adult Population (>14 Years); By End User (Clinics & Diagnostic Centers, Home Care, Private Clinics, Hospitals & Others - Global Demand Analysis & Opportunity Outlook 2027 Drug Eluting Stents Market Segmentation By Coating (Polymer-Based Coating & Polymer-Free Coating); By Application (Peripheral Artery Diseases & Coronary Artery Disease); By End User (Ambulatory Surgical Centers, Cardiology Centers & Hospitals) - Global Demand Analysis & Opportunity Outlook 2027 Gout Therapeutics Market Segmentation By Drug Class (Corticosteroids, Colchicine, Urate-Lowering Agents & NSAIDs); By Disease (Chronic Gout & Acute Gout) - Global Demand Analysis & Opportunity Outlook 2027 Parkinson’s Disease Drugs Market Segmentation By Drug Type (Marketed Drugs (Dopamine Agonists, Apomorphine, Glutamate Antagonist, Levodopa, Anticholinergics, COMT Inhibitors, MAO-B inhibitors & Others) & Pipeline Drugs)); By End Users (Clinics, Hospitals & Others) - Global Demand Analysis & Opportunity Outlook 2027
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919
For More Update Follow: - LinkedIn | Twitter | Facebook | Xing
Yahoo Finance's Dan Howley discusses reports that the DOJ is drafting an antitrust suit against Apple and what that means for rival tech companies like Google.
Biotech company Axsome Therapeutics (NASDAQ: AXSM) did not perform well in the first six months of 2022, partly due to regulatory troubles. Should investors get in on Axsome Therapeutics while it is gaining momentum, or is now a good time for shareholders to cash in and leave? On Aug. 19, Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved Auvelity to treat major depressive disorder (MDD).
According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be waning in Europe and the U.S. Public-health experts said they remain cautious about whether the outbreak has peaked as efforts continue to stretch limited vaccine supplies and protect vulnerable individuals. “If anything, we need to continue to strongly communicate and educate the public about this pathogen,” said Rodney Rohde, a public-health expert at Texas State Un
WASHINGTON (Reuters) -Global shipping container suppliers China International Marine Containers and Maersk Container Industry in a joint statement on Thursday said they have abandoned a merger plan, citing significant regulatory challenges. China International Marine Containers (CIMC) in September had agreed to buy the Danish shipping company AP Moeller - Maersk's refrigerated containers maker for $987.3 million. The U.S. Justice Department said the deal would have combined two of the world's four suppliers of refrigerated shipping containers and further concentrated the global cold supply chain.
WASHINGTON (Reuters) -The U.S. government said on Thursday it will suspend 26 China-bound flights from the United States by four Chinese carriers in response to the Chinese government's decision to suspend some U.S. carrier flights over COVID-19 cases. The decision will affect flights by Xiamen, Air China, China Southern Airlines and China Eastern Airlines from Sept. 5 to Sept. 28. The U.S. Department of Transportation (USDOT) cited the recent cancellation of 26 American Airlines, Delta Air Lines and United Airlines flights over COVID-19 cases.
'When working at home it's easy to end up working constantly, which can lead to burnout and worker dissatisfaction.'
Here’s a good bit of news for retirees in 2022: you can keep more money in your tax-deferred retirement accounts.
California will ban the sale of internal combustion engine passenger cars by 2035, officials there said on Aug. 24. The policy, coming on top of new incentives for EV buyers in the Inflation Reduction Act, could dramatically reshape the entire US vehicle fleet. California is the country’s biggest vehicle market, and more than a dozen states copy its emissions standards.
89bio Inc (NASDAQ: ETNB) announced the presentation of data from the ENTRIGUE Phase 2 proof-of-concept trial of pegozafermin in severe hypertriglyceridemia (SHTG) at the European Society of Cardiology Congress. Hypertriglyceridemia refers to an elevated level of triglycerides (a type of lipid) in the bloodstream, increasing the risk of coronary artery disease. Pegozafermin met its primary endpoint of statistically significant reductions in median triglycerides (TGs) from baseline across all dose
In addition to plowing fields, these days John Deere tractors can drive themselves, target weeds—and serve up video games.
The Medicines and Healthcare products Regulatory Agency in the U.K. has granted expanded conditional approval for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, Nuvaxovid (NVX-CoV2373), in adolescents aged 12 through 17. The approval follows the FDA nod earlier this week. "As we start to prepare for a potential fall surge, we are pleased to offer the first protein-based COVID-19 vaccine to adolescents aged 12 through 17 in the U.K.," said Stanley C. Erck, President, and CEO, of Novavax. The expa
Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss Moderna’s decision to sue rival vaccine maker Pfizer over the delivery technology used in COVID-19 vaccines.
Moderna is suing Pfizer and BioNTech over COVID-19 vaccine technology
Companies that file for bankruptcy typically receive an immediate reprieve from lawsuits, and 3M subsidiary Aearo Technologies LLC argued that extending those protections to 3M would buy Aearo time to address its debts and restructuring goals. Aearo and 3M had argued that bankruptcy offered a faster and fairer way to compensate veterans who say that earplugs made by Aearo caused hearing loss. But bankruptcy Judge Jeffrey J. Graham in Indianapolis said that Aearo's bankruptcy restructuring could proceed in parallel with the lawsuits.
Saving for a financially secure retirement is a long-term project with a sometimes indistinct final objective, especially when people are just starting in their careers. Retirement is far in the future at that point and key concerns such as career … Continue reading → The post How Much Should I Have in My 401(k) at 30? appeared first on SmartAsset Blog.
An internal survey of Boeing Co. workers authorized to perform tasks on behalf of the Federal Aviation Administration has found nearly 50% of the workers have seen improvement in management oversight in the past 12 months. The relationship between Boeing (NYSE: BA), the employees that are part of the FAA’s Organization Designation Authorization program, and the regulatory agency came under scrutiny in recent years following investigations into the development of the 737 MAX that included allegations of undue pressure to speed along the certification process. While none of Spirit’s (NYSE: SPR) work was implicated in either crash, Boeing-installed flight control software that has since been updated was acknowledged as a factor in each.
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Pfizer's response to its Moderna lawsuit allegations.
Beijing offered a rare concession Friday, agreeing to allow U.S. accounting regulators to examine the audits of Chinese firms listed on American stock exchanges.
(Bloomberg) -- The New York area is running so low on fuel that the Biden administration is warning of government action to address exports and suppliers are resorting to expensive US tankers to restock the region. Most Read from BloombergNearly 60,000 Sneakers in $85 Million Ponzi Scheme to Go on SaleGOP Fury Over ESG Triggers Backlash With US Pensions at RiskFed’s Jackson Hole Conference Is Underway: Here’s What to ExpectWorld’s Most Popular Password Manager Says It Was HackedA 129-Foot Supery
An American classic, Coca-Cola (NYSE: KO) has been refreshing customers since 1886. If all that doesn't convince you that it's a solid investment, here's another fun fact about Coke: Its biggest shareholder is none other than Warren Buffett, who says he'll never sell a single share. Here are five reasons why Coca-Cola has remained the undisputed leader in carbonated beverages for over 100 years.